Overview
SOPH market data
Price History
SOPH price chart · 1M
- O
- 8.66
- H
- 8.92
- L
- 8.46
- C
- 8.91
- Vol
- 28,731.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $8.66
- Previous Close
- $8.54
- Day High
- $8.92
- Day Low
- $8.46
- 52 Week High
- $8.92
- 52 Week Low
- $4.55
- 7 Day Return
- +7.09%
- 30 Day Return
- +59.68%
- 90 Day Return
- +77.49%
- 1 Year Return
- +68.75%
- Daily Notional Volume
- $256K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.17 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.93 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -93.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.10 – $8.85 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $639.3M · P/B 6.72 · P/S 7.42.
Company News
AI Poised to Reshape Blood Cancer Therapeutics as Investment Surges Past $2 Billion Across Leading Biotech and Pharma PlayersGlobenewswire Inc · Aug 25, 2026, 5:15 PM
HC Wainwright & Co. Maintains Buy on Sophia Genetics, Raises Price Target to $14Benzinga · Aug 5, 2026, 10:28 AM
BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $9Benzinga · Aug 5, 2026, 10:05 AM
SOPHiA GENETICS shares are trading higher after the company reported better-than-expected Q2 sales results and raised its FY26 sales guidance above analyst estimates.Benzinga · Aug 4, 2026, 2:46 PM
Sophia Genetics Raises FY2026 Sales Guidance from $92.000M-$94.000M to $94.000M-$96.000M vs $93.403M EstBenzinga · Aug 4, 2026, 10:46 AM
Sophia Genetics Q2 EPS $(0.30) Misses $(0.20) Estimate, Sales $23.310M Beat $21.729M EstimateBenzinga · Aug 4, 2026, 10:46 AM
SOPHiA GENETICS Announces Global Collaboration To Develop, Validate, And Deploy Two Companion Diagnostics Supporting Precision Oncology Therapies With AstraZenecaBenzinga · Aug 4, 2026, 10:19 AM
Sophia Genetics shares are trading higher after HC Wainwright & Co. initiated coverage on the stock with a Buy rating and announced a $12 price target.Benzinga · Jul 20, 2026, 4:57 PM
This Charles Schwab Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For MondayBenzinga · Jul 20, 2026, 12:39 PM
This Urban Outfitters Analyst Turns Bullish; Here Are Top 5 Upgrades For MondayBenzinga · Jul 20, 2026, 11:28 AM